Methylphenidate treatment in adolescent rats with an attention deficit/hyperactivity disorder phenotype: cocaine addiction vulnerability and dopamine transporter function.
about
Sensitive periods of substance abuse: Early risk for the transition to dependenceCocaine-seeking behavior in a genetic model of attention-deficit/hyperactivity disorder following adolescent methylphenidate or atomoxetine treatmentsPrefrontal cortical and striatal transcriptional responses to the reinforcing effect of repeated methylphenidate treatment in the spontaneously hypertensive rat, animal model of attention-deficit/hyperactivity disorder (ADHD).Convergent pharmacological mechanisms in impulsivity and addiction: insights from rodent models.Methylphenidate and μ opioid receptor interactions: a pharmacological target for prevention of stimulant abuse.Methylphenidate treatment beyond adolescence maintains increased cocaine self-administration in the spontaneously hypertensive rat model of attention deficit/hyperactivity disorder.Long Withdrawal of Methylphenidate Induces a Differential Response of the Dopaminergic System and Increases Sensitivity to Cocaine in the Prefrontal Cortex of Spontaneously Hypertensive Rats.Effect of methylphenidate treatment during adolescence on norepinephrine transporter function in orbitofrontal cortex in a rat model of attention deficit hyperactivity disorder.Increased dopamine transporter function as a mechanism for dopamine hypoactivity in the adult infralimbic medial prefrontal cortex following adolescent social stressChronic treatment with extended release methylphenidate does not alter dopamine systems or increase vulnerability for cocaine self-administration: a study in nonhuman primatesAdolescent D-amphetamine treatment in a rodent model of ADHD: Pro-cognitive effects in adolescence without an impact on cocaine cue reactivity in adulthood.Adolescent methylphenidate treatment differentially alters adult impulsivity and hyperactivity in the Spontaneously Hypertensive Rat model of ADHD.Performance on a strategy set shifting task during adolescence in a genetic model of attention deficit/hyperactivity disorder: methylphenidate vs. atomoxetine treatmentsHighly impulsive rats: modelling an endophenotype to determine the neurobiological, genetic and environmental mechanisms of addictionNovelty-induced conditioned place preference, sucrose preference, and elevated plus maze behavior in adult rats after repeated exposure to methylphenidate during the preweanling period.Necessity for research directed at stimulant type and treatment-onset age to access the impact of medication on drug abuse vulnerability in teenagers with ADHDIsolation rearing as a preclinical model of attention/deficit-hyperactivity disorderAdolescence methylphenidate treatment in a rodent model of attention deficit/hyperactivity disorder: dopamine transporter function and cellular distribution in adulthood.The effects of rearing environment and chronic methylphenidate administration on behavior and dopamine receptors in adolescent ratsLurasidone : in the treatment of schizophrenia.Abuse and dependence liability analysis of methylphenidate in the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder (ADHD): what have we learned?Exposure to methylphenidate during infancy and adolescence in non-human animals and sensitization to abuse of psychostimulants later in life: a systematic review.Methylphenidate has nonlinear dose effects on cued response inhibition in adults but not adolescents.Gene expression profiling in the striatum of amphetamine-treated spontaneously hypertensive rats which showed amphetamine conditioned place preference and self-administration.Differential sensitivity to the acute and sensitizing behavioral effects of methylphenidate as a function of strain in adolescent and young adult rats.Age-related changes in prefrontal norepinephrine transporter density: The basis for improved cognitive flexibility after low doses of atomoxetine in adolescent rats.Adolescent atomoxetine treatment in a rodent model of ADHD: effects on cocaine self-administration and dopamine transporters in frontostriatal regions.Drugs for kids: good or bad?Blockade of α2-adrenergic receptors in prelimbic cortex: impact on cocaine self-administration in adult spontaneously hypertensive rats following adolescent atomoxetine treatment.Adolescent d-amphetamine treatment in a rodent model of attention deficit/hyperactivity disorder: impact on cocaine abuse vulnerability in adulthood.
P2860
Q28075281-27C09B59-5B54-4875-9DA9-CF5B3A81E09DQ30581979-1A3397AE-79EF-41D2-80A0-FB4DE3303639Q30582194-6ABBA3CC-B72B-46E7-BB8B-4F2BE6381452Q34407185-35276573-00CB-4BD3-AD74-D6525FD367B4Q35016913-1E03F586-2002-49FB-92A0-AC343AE1612DQ35205459-8E557437-2ADE-4F16-93AC-F0E777141AC0Q35824437-F18462DC-FE91-495D-B8A9-FDE7B8C09F47Q35908982-14DD4C4C-056F-4FFA-B3DB-06248A7FE544Q35956198-D6FE497C-49CD-4971-8ACD-BA5C46AC2255Q36323506-8BDA9756-7E1D-4D34-BA9E-5E1D06E5C2DAQ36372705-6525F7C5-97BA-42B9-95D4-53BF878B1127Q36611015-7E12390E-561F-413F-9272-80105EF6282FQ36681100-A3DDBA41-537A-4EBA-8D35-F4D4A4881408Q36683023-527C8A50-5F23-425B-9C93-944B1132F430Q36796650-ADDF9777-0469-4F5D-97D8-60F4917B29B1Q36892982-5A9EBC73-0843-4A6D-8A31-C1CF37598F86Q36912231-739F5F3A-48D8-4B24-A154-6CED2A735260Q37005445-6C7A92F8-14D8-48AD-8E40-61BFA16997F0Q37177669-680BEF7D-9359-4D66-91DC-096C4CD097D2Q38069538-2E6E564D-C33E-4521-A8E3-4D16B139456DQ38087534-838F1867-2FAD-476A-B713-F8B390913D92Q38656883-AE27FB8A-AA8B-44B8-A31A-403BE0F45A52Q38901642-DF804F81-4485-479F-AD0D-A958C7DA5C74Q39138814-A6682994-C829-4E24-84D7-F2C8A6179E69Q39433547-39FBB2DB-C0EC-4BB3-95C9-353AC2D34FBDQ41967394-CDDA0A3C-C139-4A06-8C05-D3024F6C222FQ42007774-8926D411-0C01-4A74-B803-C5BC589C1A4CQ42326520-323F3123-2A8A-49D3-A5BF-00870E146298Q48186009-287EAF95-7C5B-4357-B320-B06273924C23Q48527671-DE1DF42D-DB95-4280-B61E-6AF31EC4A95A
P2860
Methylphenidate treatment in adolescent rats with an attention deficit/hyperactivity disorder phenotype: cocaine addiction vulnerability and dopamine transporter function.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Methylphenidate treatment in a ...... dopamine transporter function.
@ast
Methylphenidate treatment in a ...... dopamine transporter function.
@en
type
label
Methylphenidate treatment in a ...... dopamine transporter function.
@ast
Methylphenidate treatment in a ...... dopamine transporter function.
@en
prefLabel
Methylphenidate treatment in a ...... dopamine transporter function.
@ast
Methylphenidate treatment in a ...... dopamine transporter function.
@en
P2093
P2860
P921
P356
P1476
Methylphenidate treatment in a ...... dopamine transporter function.
@en
P2093
Agripina Deaciuc
Kathleen M Kantak
Linda P Dwoskin
Roxann C Harvey
Sucharita Sen
P2860
P2888
P304
P356
10.1038/NPP.2010.223
P407
P577
2010-12-08T00:00:00Z
P5875
P6179
1030353736